The University will use the SOPHiA DDM™ Platform to enhance blood cancer testing and research...
Press releases
SOPHiA GENETICS Supports Genetic Testing in Brazil
The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing...
SOPHiA GENETICS Named in Built In’s Esteemed 2024 Best Places To Work Awards
Boston, MA – January 22, 2024 — SOPHiA GENETICS announced today that it was honored by Built In on...
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panel BOSTON MA...
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India
SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos...
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
Strong SOPHiA DDM™ adoption and analysis volume contributes to continued revenue growth ...
Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics
Boston, MA and Rolle, Switzerland, January 8, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a...
Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid Disorders
The Hospital will use SOPHiA GENETICS technology to streamline workflows and expedite...
OmiCure® is Live on SOPHiA GENETICS
OmiCure uses the SOPHiA DDM™ Platform to advance its testing technology BOSTON, United States and...
SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
BOSTON & ROLLE, Switzerland (December 14, 2023) --- SOPHiA GENETICS (NASDAQ:...
SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings
World-class liquid biopsy testing will be available to SOPHiA GENETICS customers Boston, MA and...
SOPHiA GENETICS Announces Expansion of Work with CHU de Nîmes
Through the expanded relationship CHU de Nîmes will advance its research of rare and inherited...